A Phase II Study of Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Cabazitaxel (Primary) ; Pegfilgrastim
- Indications Urogenital cancer
- Focus Therapeutic Use
- 10 May 2017 Status changed from active, no longer recruiting to completed.
- 08 Sep 2016 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018.
- 08 Sep 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Aug 2017.